Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bp Consulting, Inc
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female \>18 years of age scheduled to undergo argon laser therapy. Patients with diabetic macular edema (DME) and/or proliferative diabetic retinopathy as evidenced by ophthalmic examination and diagnostics, with either central macular or peripheral involvement.
Female subjects of childbearing potential must have a normal menstrual cycle and a negative urine pregnancy test result prior to study entry. Women must be either post-menopausal or surgically sterile (hysterectomy, bilateral tubal ligation, or bilateral oopherectomy), or women of childbearing potential must use an effective method of birth control. Acceptable methods of birth control include hormonal contraceptives (i.e. pill, patch, ring, injection, implant), intrauterine device (IUD), diaphragm with spermicide or condom with spermicide.
The incidence of DME will be determined by 2 methods:
* Diagnosis of clinical DME can be made by the masked investigator during the study based on the investigator's medical opinion and expertise
* Diagnosis of DME by a masked clinical specialist will review all Optical Coherence Tomography (OCT) after conclusion of study. The diagnosis will be stratified into 3 categories:
* Definite DME: retinal swelling or blurred vision.
* Probable DME: Presence of changes in retinal swelling or blurred vision noted from baseline to follow up.
* Possible DME: subtle to moderate changes in retinal swelling or blurred vision noted.
Best Corrected Visual Acuity (BCVA) ranging between 20/40 and 20/400.
You may not be if
Patients who received intra-vitreal/sub-tenon corticosteroid injections.